Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland -
Clinic of Vascular and Internal Medicine, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, Bydgoszcz, Poland -
Minerva Cardiol Angiol. 2021 Apr;69(2):161-171. doi: 10.23736/S2724-5683.20.05114-2. Epub 2020 Jul 8.
Lower extremity artery disease (LEAD) involves progressive arterial narrowing manifested by intermittent claudication (IC). LEAD entails endothelial dysfunction and fibrinolytic disorders. In the current study, we analyze the selected parameters of the fibrinolytic system in the blood of patients with symptomatic LEAD depending on clinical parameters.
The test group was comprised of 80 patients with diagnosis of LEAD based on Ankle-Brachial Index (ABI) test (27 female/53 male) with an average age of 63.5±9 years. The control group included 30 healthy, non-smoking volunteers (10 female/20 male), with the median age of 56±6 years. The research material - venous blood - was sampled to determine the concentrations of tissue-type plasminogen activator (t-PA Ag), plasminogen activator inhibitor type 1 (PAI-1 Ag), D-dimer, fibrinogen, and platelet count (PLT).
We found elevated concentrations of t-PA Ag, PAI-1 Ag, D-dimer, and fibrinogen in the plasma of subjects with symptomatic LEAD. Various stages of the Fontaine classification demonstrated a gradual, statistically significant increase in the concentrations of fibrinogen and PLT count as the disease progressed. More so, in the subgroup of LEAD patients aged ≥65 years, we observed significantly higher levels of D-dimer than in the group of younger subjects. In addition to that, the LEAD group demonstrated negative correlations of IC distance, fibrinogen concentrations, and PLT count, negative correlations of ABI at rest and concentrations of D-dimer and PLT count, as well as positive correlations between age and D-dimer levels.
High t-PA Ag concentrations in LEAD patients suggest damage to the endothelium which comprises the main source of this factor. With high PAI-1 Ag levels, inactive fibrinolytic t-PA-PAI-1 complexes are formed. Increasing fibrinogen concentrations at the subsequent stages in accordance with the Fontaine classification, indicate increasing inflammation. Moreover, heightened values of D-dimer reflect an increased secondary fibrinolysis activation as patients get older and impaired extremity vascularization, manifested by the decreasing ABI, progresses.
下肢动脉疾病(LEAD)涉及渐进性动脉狭窄,表现为间歇性跛行(IC)。LEAD 涉及内皮功能障碍和纤维蛋白溶解障碍。在目前的研究中,我们根据临床参数分析了有症状的 LEAD 患者血液中纤维蛋白溶解系统的选定参数。
实验组由 80 名根据踝臂指数(ABI)测试诊断为 LEAD 的患者组成(27 名女性/53 名男性),平均年龄为 63.5±9 岁。对照组包括 30 名健康、不吸烟的志愿者(10 名女性/20 名男性),中位年龄为 56±6 岁。研究材料 - 静脉血 - 被抽取以确定组织型纤溶酶原激活物(t-PA Ag)、纤溶酶原激活物抑制剂 1(PAI-1 Ag)、D-二聚体、纤维蛋白原和血小板计数(PLT)的浓度。
我们发现有症状的 LEAD 患者血浆中 t-PA Ag、PAI-1 Ag、D-二聚体和纤维蛋白原浓度升高。随着疾病的进展,Fontaine 分类的各个阶段显示纤维蛋白原和 PLT 计数逐渐增加,且具有统计学意义。更重要的是,在年龄≥65 岁的 LEAD 患者亚组中,我们观察到 D-二聚体水平明显高于年轻组。此外,LEAD 组还显示 IC 距离、纤维蛋白原浓度和 PLT 计数呈负相关,静息 ABI 与 D-二聚体和 PLT 浓度呈负相关,年龄与 D-二聚体水平呈正相关。
LEAD 患者中高浓度的 t-PA Ag 表明内皮损伤,这是该因子的主要来源。高 PAI-1 Ag 水平会形成无活性的纤维蛋白溶解 t-PA-PAI-1 复合物。根据 Fontaine 分类,在后续阶段纤维蛋白原浓度升高表明炎症增加。此外,随着患者年龄的增长和肢体血管化受损,D-二聚体值升高反映继发性纤维蛋白溶解激活增加,ABI 降低。